## MDB: MongoDB, Inc. - XLK: Technology

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 8.0% in mid entry zone (4.0-10.0%), top 4% cross-sectional ranking. Short-term MRS_5 (0.3%) confirms momentum alignment. Outperforming sector by 7.8%. Caution: declining volume (53% of avg), momentum weakening (-2.8% MRS).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($407.15)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 26, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Raymond James | $0 | $0 | 0% |
| 2025-12-04 | Argus Research | $488 | $340 | +44% |
| 2025-12-03 | Citigroup | $525 | $440 | +19% |
| 2025-12-03 | Goldman Sachs | $475 | $405 | +17% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Raymond James | init | Market Perform |
| 2025-12-04 | Argus Research | main | Buy |
| 2025-12-03 | Citigroup | main | Buy |
| 2025-12-03 | Goldman Sachs | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 17 ($14.36M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 36.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 10 / 0 |

**Top Holders:**
- Vanguard Group Inc: 11.0% (+5.0%)
- Blackrock Inc.: 6.1% (+3.6%)
- Morgan Stanley: 3.3% (+52.2%)
- JPMORGAN CHASE & CO: 2.8% (+34.0%)
- ValueAct Holdings, L: 2.6% (+206.8%)

### Key Risks

1. Heavy insider selling: $14M sold (17 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 26 raises (avg +20%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.67 elevated, pricing in significant growth expectations. Forward P/E 78.7x stretched relative to 15% growth. Balance sheet: strong liquidity (5.2x), low leverage (D/E 0.23). Analyst sentiment positive (26 raises, avg +20%). Insider selling cluster ($14.4M in 90 days), potential headwind. Institutional flow bullish (10 buying vs 0 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $35.6B |
| Beta | 1.45 |
| 52W Range | $140.78 - $440.67 |
| Short Interest | 4.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.67 |
| Forward P/E | 78.7 |
| Current P/E | 90.8 |
| YoY Growth | 15.3% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 10.8% to 8.0% (-2.8% in 5 days), indicating relative weakness vs NASDAQ. Currently in upper STRENGTH zone (4.0-10.0%), cross-sectional ranking at 96th percentile. MRS_5 at 0.3% confirms short-term momentum alignment. AM_20 at 9.1% shows strong absolute momentum above own 20MA. Outperforming sector by 7.8pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.60), confirming momentum. Volume at 53% of 20MA suggests lack of conviction. OFD pattern: -SLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 8.00% (CS: 96) | Strong |
| RSI_14 | 69.1 | Neutral |
| MACD Histogram | 1.60 | Bullish |
| vs SMA20 | 1.091x | Above |
| vs SMA50 | 1.198x | Above |
| vs SMA200 | 1.684x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $437.13
- **Stop Loss:** $407.15 (6.9% risk)
- **Target:** $482.10 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 40
- **Position Value:** $17,485.20
- **Portfolio %:** 17.49%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-03-05 (Est: $1.48)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.79 | $1.32 | +66.9% |
| 2025Q3 | $0.66 | $1.00 | +52.4% |
| 2025Q2 | $0.66 | $1.00 | +52.0% |
| 2025Q1 | $0.67 | $1.28 | +91.1% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*